Related Experiment Video
Updated: Apr 15, 2026
05:56
Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
Published on: June 21, 2024
2.6K
Opioid-induced nausea and vomiting.
Howard S Smith1, Joshua M Smith2, Pya Seidner3
1Albany Medical College, Department of Anesthesiology, 47 New Scotland Avenue; MC-131, Albany, New York 12208, USA. smithh@mail.amc.edu.
Annals of Palliative Medicine
|April 6, 2015
Summary
Opioid analgesics help manage pain in palliative care but can cause nausea and vomiting. Current strategies may help reduce these common opioid side effects for patients.
Area of Science:
- Palliative Care Medicine
- Pharmacology
- Gastroenterology
Background:
- Opioids are essential for pain management in palliative care.
- Opioid use is frequently associated with adverse effects, including nausea and vomiting.
- Managing these side effects is crucial for patient comfort and treatment adherence.
Purpose of the Study:
- To review current strategies for mitigating opioid-induced nausea and vomiting (OINV).
- To highlight the significance of OINV as a challenge in palliative care.
- To explore potential therapeutic approaches for OINV.
Main Methods:
- Literature review of existing studies on opioid analgesics and antiemetic strategies.
- Analysis of the incidence and impact of nausea and vomiting in patients receiving opioids.
- Identification of current and emerging interventions for OINV.
Main Results:
- Nausea and vomiting are significant adverse effects of opioid therapy.
- Despite the availability of opioids, OINV remains a challenge for many patients.
- Several strategies exist to manage and potentially reduce OINV frequency and intensity.
Conclusions:
- Opioid-induced nausea and vomiting require effective management strategies.
- Further research into combination therapies may offer future solutions.
- Addressing OINV is vital for improving the quality of life for palliative care patients.
Related Concept Videos
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
1.1K
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
1.1K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
785
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
785
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
1.2K
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
1.2K
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
910
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
910
01:17Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
971
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
971
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
1.6K
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.6K